NRI — Autoantibodies, Nuclear Pore Glycoprotein Gp210 Class II

FDA Device Classification

FDA product code NRI covers "Autoantibodies, Nuclear Pore Glycoprotein Gp210", a Class II medical device regulated under 21 CFR 866.5090. Submissions are reviewed by the Immunology panel. At least 2 recent 510(k) clearances have been granted under this product code.

Classification Details

Product Code
NRI
Device Class
Class II
Regulation Number
866.5090
Submission Type
Review Panel
IM
Medical Specialty
Immunology
Implant
No

Definition

The device is used for the detection, in human serum or plasma, of autoantibodies to gp210 (nuclear pore glycoprotein gp210) as an aid in the diagnosis of primary biliary cirrhosis.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K061842inova diagnosticsQUANTA LITE PBC SCREEN IGG/IGA ELISAOctober 18, 2006
K040885inova diagnosticsQUANTA LITE GP210 ELISAJune 25, 2004